Building PM Capabilities

By Ivanna Rosendal, VP and global head of digitalization, Ascendis Pharma What does it take to start clinical trials in just days and pivot when the trial dictates it? Not our current approach. Rather than our current focus on systems supporting clinical trials, we need to build the capabilities that deliver the same functionality in many different modalities. These modalities should align with the clinical trial we want to run, not determine how we run it.

Picture this: you are a Product Director, with several Product Managers reporting to you. One of your PMs comes to you for advice as they are struggling to communicate the direction and scope of work to their team, even though they are confident they know it. Complicating this is that some members of the broader team have also made clear to you that that they’re struggling to understand the team’s direction or scope, and believe the PM hasn’t got a solid story.